NEW YORK, Aug. 16, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of BioScrip, Inc. BIOS, Powell Industries, Inc. POWL, Portola Pharmaceuticals, Inc. PTLA, Daktronics, Inc. DAKT, Cable One, Inc. CABO, and Park-Ohio Holdings Corp. PKOH, including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
BIOS DOWNLOAD: http://Fundamental-Markets.com/register/?so=BIOS
POWL DOWNLOAD: http://Fundamental-Markets.com/register/?so=POWL
PTLA DOWNLOAD: http://Fundamental-Markets.com/register/?so=PTLA
DAKT DOWNLOAD: http://Fundamental-Markets.com/register/?so=DAKT
CABO DOWNLOAD: http://Fundamental-Markets.com/register/?so=CABO
PKOH DOWNLOAD: http://Fundamental-Markets.com/register/?so=PKOH
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine BioScrip, Inc. BIOS, Powell Industries, Inc. POWL, Portola Pharmaceuticals, Inc. PTLA, Daktronics, Inc. DAKT, Cable One, Inc. CABO, and Park-Ohio Holdings Corp. PKOH on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed August 14th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
BIOSCRIP, INC. (BIOS) REPORT OVERVIEW
BioScrip's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, BioScrip reported revenue of $175.79MM vs $218.11MM (down 19.40%) and basic earnings per share -$0.14 vs -$0.26. For the twelve months ended December 31st, 2017 vs December 31st, 2016, BioScrip reported revenue of $817.19MM vs $935.59MM (down 12.66%) and basic earnings per share -$0.60 vs -$0.55. BioScrip is expected to report earnings on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.12. The estimated EPS forecast for the next fiscal year is -$0.16 and is expected to report on March 14th, 2019.
To read the full BioScrip, Inc. (BIOS) report, download it here: http://Fundamental-Markets.com/register/?so=BIOS
-----------------------------------------
POWELL INDUSTRIES, INC. (POWL) REPORT OVERVIEW
Powell Industries' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Powell Industries reported revenue of $122.13MM vs $85.93MM (up 42.13%) and basic earnings per share $0.03 vs -$0.28. For the twelve months ended September 30th, 2017 vs September 30th, 2016, Powell Industries reported revenue of $395.91MM vs $565.24MM (down 29.96%) and basic earnings per share -$0.83 vs $1.36. Powell Industries is expected to report earnings on December 4th, 2018. The report will be for the fiscal period ending September 30th, 2018.
To read the full Powell Industries, Inc. (POWL) report, download it here: http://Fundamental-Markets.com/register/?so=POWL
-----------------------------------------
PORTOLA PHARMACEUTICALS, INC. (PTLA) REPORT OVERVIEW
Portola Pharmaceuticals' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Portola Pharmaceuticals reported revenue of $4.01MM vs $3.79MM (up 5.91%) and basic earnings per share -$1.61 vs -$1.22. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Portola Pharmaceuticals reported revenue of $22.55MM vs $35.50MM (down 36.50%) and basic earnings per share -$4.81 vs -$4.76. Portola Pharmaceuticals is expected to report earnings on November 5th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$1.41. The estimated EPS forecast for the next fiscal year is -$3.97 and is expected to report on February 27th, 2019.
To read the full Portola Pharmaceuticals, Inc. (PTLA) report, download it here: http://Fundamental-Markets.com/register/?so=PTLA
-----------------------------------------
DAKTRONICS, INC. (DAKT) REPORT OVERVIEW
Daktronics' Recent Financial Performance
For the three months ended April 30th, 2018 vs April 30th, 2017, Daktronics reported revenue of $138.18MM vs $143.68MM (down 3.83%) and basic earnings per share -$0.08 vs $0.01. For the twelve months ended April 30th, 2018 vs April 30th, 2017, Daktronics reported revenue of $610.53MM vs $586.54MM (up 4.09%) and basic earnings per share $0.13 vs $0.23 (down 43.48%). Daktronics is expected to report earnings on August 21st, 2018. The report will be for the fiscal period ending July 31st, 2018.
To read the full Daktronics, Inc. (DAKT) report, download it here: http://Fundamental-Markets.com/register/?so=DAKT
-----------------------------------------
CABLE ONE, INC. (CABO) REPORT OVERVIEW
Cable One's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Cable One reported revenue of $268.41MM vs $240.99MM (up 11.38%) and basic earnings per share $7.70 vs $4.91 (up 56.82%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Cable One reported revenue of $960.03MM vs $819.63MM (up 17.13%) and basic earnings per share $41.20 vs $17.60 (up 134.09%). Cable One is expected to report earnings on November 14th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $5.48. The estimated EPS forecast for the next fiscal year is $33.92 and is expected to report on March 7th, 2019.
To read the full Cable One, Inc. (CABO) report, download it here: http://Fundamental-Markets.com/register/?so=CABO
-----------------------------------------
PARK-OHIO HOLDINGS CORP. (PKOH) REPORT OVERVIEW
Park-Ohio's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Park-Ohio reported revenue of $432.20MM vs $350.90MM (up 23.17%) and basic earnings per share $1.20 vs $0.25 (up 380.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Park-Ohio reported revenue of $1,412.90MM vs $1,276.90MM (up 10.65%) and basic earnings per share $2.34 vs $2.62 (down 10.69%). Park-Ohio is expected to report earnings on November 5th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.82. The estimated EPS forecast for the next fiscal year is $4.32 and is expected to report on March 4th, 2019.
To read the full Park-Ohio Holdings Corp. (PKOH) report, download it here: http://Fundamental-Markets.com/register/?so=PKOH
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
